# Omegaven Protocol:Intermediate Size Patient Population

> **NCT03561194** · — · APPROVED_FOR_MARKETING · sponsor: **DHR Health Institute for Research and Development**

## Conditions studied

- Parenteral Nutrition Associated Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Omegaven

## Key facts

- **NCT ID:** NCT03561194
- **Lead sponsor:** DHR Health Institute for Research and Development
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03561194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03561194, "Omegaven Protocol:Intermediate Size Patient Population". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03561194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*